Release Date: 30/10/18 18:03 Summary: Quarterly Activities Report - September 2018 Price Sensitive: Yes Download Document 209.39KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%